Cerebrovascular Disease and Statins
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of atherosclerotic cardiovascular disease (ASCVD); accordingly, LDL-C lowering is associated with a decreased risk of progression of atherosclerotic plaques and development of complications. Currently, statin...
Enregistré dans:
| Auteurs principaux: | Luis M. Beltrán Romero, Antonio J. Vallejo-Vaz, Ovidio Muñiz Grijalvo |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8a3d8d1292df457a84358aad93f70458 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Loss of Hepatic Surf4 Depletes Lipid Droplets in the Adrenal Cortex but Does Not Impair Adrenal Hormone Production
par: Xiaole Chang, et autres
Publié: (2021) -
Statins in Non-alcoholic Steatohepatitis
par: Jose D. Torres-Peña, et autres
Publié: (2021) -
Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
par: John N. Booth, et autres
Publié: (2018) -
Enfermedad cerebrovascular y estatinas
par: Prat,Hernán
Publié: (2012) -
Statin Therapy in Very Old Patients: Lights and Shadows
par: Lidia Cobos-Palacios, et autres
Publié: (2021)